What is the variability of serum Insulin-like Growth Factor-1 (IGF-1) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Serum Insulin-like Growth Factor-1 (IGF-1) levels can vary significantly due to various factors, including age, sex, Tanner stage, and underlying medical conditions.

Factors Affecting IGF-1 Levels

  • Age and sex: IGF-1 levels are age-adjusted and sex-adjusted, and normal ranges vary accordingly 1
  • Tanner stage: IGF-1 levels are also Tanner stage-matched, as levels can fluctuate during puberty 1
  • Medical conditions: Certain conditions, such as hypothyroidism, malnutrition, severe infection, poorly controlled diabetes mellitus, hepatic and/or renal failure, and oral oestrogen use, can affect IGF-1 levels 1

Inter-Assay Variability

  • Local Tanner stage-matched, sex-matched, and age-matched normal ranges for the IGF-1 assay must be established to avoid notable inter-assay variability 1

Clinical Interpretation

  • Elevated IGF-1 levels can indicate GH excess, but marginal or mild elevation in adolescence requires cautious interpretation 1
  • IGF-1 levels should be interpreted within a clinical assessment of phenotype, including height velocity, pubertal stage, and bone age 1

Biochemical Outcomes

  • Elevated GH and IGF-I levels are predictors of mortality in patients with acromegaly, and normalizing IGF-I levels can result in mortality rates similar to those expected in the general population 1

From the Research

Variability of Serum Insulin-like Growth Factor-1 (IGF-1) Levels

  • The variability of serum IGF-1 levels can be influenced by several factors, including age, sex, and body mass index (BMI) 2, 3.
  • Studies have shown that IGF-1 levels decline with aging in adults, and there are statistically significant differences in IGF-1 levels between men and women in some subgroups of age 2.
  • The reference ranges for IGF-1 levels can vary depending on the population being studied, and it is essential to establish age- and gender-specific normal ranges for different populations 2, 4.
  • Biological variability and method-specific assay performance issues can also contribute to the variability of serum IGF-1 levels 5.
  • Additionally, the use of different platforms for measuring IGF-1 levels can result in significant variations, highlighting the need for standardization in IGF-1 measurement 6.

Factors Influencing IGF-1 Variability

  • Age: IGF-1 levels decline with aging in adults 2, 4.
  • Sex: There are statistically significant differences in IGF-1 levels between men and women in some subgroups of age 2.
  • Body Mass Index (BMI): Age and BMI are independent predictors of serum IGF-1 values, accounting for 39% of IGF-1 variability 3.
  • Assay performance: Method-specific assay performance issues can contribute to the variability of serum IGF-1 levels 5, 6.

Clinical Implications

  • The variability of serum IGF-1 levels can have significant implications for the diagnosis and management of patients with growth hormone-related disorders 4, 6.
  • Clinicians should be aware of the potential factors influencing IGF-1 variability and take them into consideration when interpreting IGF-1 results 5, 6.
  • Standardization of IGF-1 measurement is essential to ensure accurate and reliable results, particularly when switching from one platform to another 6.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.